The Global Forum on Bioethics in Research (GFBR) will hold a two-day meeting in Toronto, Canada on June 8-9, 2021 (tentative) on the theme “Ethical issues arising in research with people with mental health conditions”.
Meaningful research is required to advance the health of people with mental health conditions, but this has been stymied by a lack of mental health resources in low- and middle- income countries (LMICs) and the ethical and legal challenges faced by researchers globally. There is a need for a more nuanced understanding of how mental health is understood and experienced in diverse contexts, decisional capacity and how to assess it, how stigma and discrimination can be mitigated, and how to address the complex vulnerabilities that people living with mental health conditions may experience. These issues apply not only to mental health research but to research more broadly where exclusionary criteria may prevent the participation of people with mental health conditions resulting in an evidence base for their care that is poorer than for other populations. This is a significant issue given the comorbidity between mental health conditions and physical illness. By addressing these ethical and legal challenges GFBR aims to advance the health of people with mental health conditions by promoting their appropriate and ethical inclusion in research.
As part of the upcoming meeting, the GFBR is seeking case studies that bring attention to key ethical issues that have emerged regarding the involvement of people with mental health conditions in research in LMIC settings. Case studies on the ethics of mental health research are also invited. We will also have a session on governance issues. We are seeking proposals that provide an overview and critique of existing laws, guidance or policy from a LMIC perspective and/or that also identify gaps and propose solutions. The GFBR is also seeking participants and journalists to attend the meeting, with places awarded on a competitive basis.
Successful applicants from LMICs will receive an award to cover the cost of their travel, accommodation and single-entry visa.
Please note: In light of the COVID-19 pandemic, the meeting date will be kept under review and may be postponed until later if necessary.
Application deadline is November 4, 2020. Please click here for more information.
nhlbi announces participation in pa-18-932 "increasing uptake of evidence-based screening in diverse adult populations (ro1 clinical trial optional)
The National Heart, Lung, and Blood institute (NHLBI) seeks research proposals that would produce generalizable new knowledge informing screening strategies in high-burden and underserved communities and populations, to reduce disparities in screening. Grant applications should address conditions for which there is already good evidence of benefit from screening at least in some demographic or clinical subgroups. Applications could address screening for conditions where the supportive evidence is considered insufficient by the US Preventative Services Task Force (USPSTF), such as atrial fibrillation and obstructive sleep apnea, but for which screening is recommended by at least one major organization, such as the American Heart Association (AHA), American College of Cardiology (ACC), the American College of Physicians (ACP), and the American Academy of Sleep Medicine (AASM). Variation in clinical screening practice guideline recommendations for HBLS conditions such as atrial fibrillation, abdominal aortic aneurysm, and obstructive sleep apnea calls for strengthening the evidence base for prevention screening modalities. NHLBI is interested in supporting applications that also focus on high-risk and underserved/under screened clinical and demographic subgroups where the likelihood of benefit from screening is stronger (e.g., atrial fibrillation in rural populations, older persons, and those with hypertension or diabetes; hypertension in younger persons and men; and obstructive sleep apnea in morbidly obese persons). Proposed screening strategies should have potential to be scalable, sustainable, and affordable. Standard R01 application due dates apply. The Please visit https://grants.nih.gov/grants/guide/notice-files/NOT-HL-19-719.html for more details.
OSI Specific Aims Speed Review for son facultY
The Office for Science and Innovation (OSI) offers Specific Aims Speed Review sessions for faculty. These interactive sessions are open to all School of Nursing faculty and feature speed reviews of aims pages by both senior faculty and attending peers.
Please email the OSI to express your interest to have a speed aims review. The date of the live review will be confirmed based on availability of reviewers and participants.
If you have any questions please don’t hesitate to contact us or stop by the OSI!
Office for Science and Innovation (OSI)
Johns Hopkins University School of Nursing
525 North Wolfe Street, Room 331
Phone: (410) 614-7005